Co-dydramol
This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. (February 2014) |
| Combination of | |
|---|---|
| Dihydrocodeine | Opioid analgesic |
| Paracetamol | Non-opioid analgesic |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | ~20% (Oral) |
| Identifiers | |
| CAS Number | |
| (verify) | |
Co-dydramol (BAN) is a non-proprietary name used to denote a particular compound analgesic, a combination of dihydrocodeine tartrate and paracetamol. Co-dydramol tablets are used for the relief of moderate pain. Co-dydramol is part of a series of combination drugs available in the UK and other countries including co-codaprin (aspirin and codeine).
Formulations
[edit]All formulations of co-dydramol contain 500 mg of paracetamol per tablet and may only be sold at a pharmacy as an over-the-counter item without prescription (a P medicine) if containing less than 7.5 mg of dihydrocodeine per tablet. Higher strengths are prescription only medicines. There are no GSL formulations of co-dydramol, as it is a Schedule 5 controlled drug. Four strengths of dihydrocodeine tartrate in each tablet are available:
- 7.46 mg dihydrocodeine as co-dydramol 7.46/500 (e.g. in the branded product Paramol).
- 10 mg dihydrocodeine as co-dydramol 10/500, this is also the preparation to be dispensed if no strength is specified on a prescription.
- 20 mg dihydrocodeine as co-dydramol 20/500 (e.g. branded products Paracod 500/20 and Remedeine).
- 30 mg dihydrocodeine as co-dydramol 30/500 (e.g. branded products Paracod 500/30 and Remedeine Forte).
Metabolism
[edit]Dihydrocodeine is metabolised by the CYP450 system isoenzyme 2D6 to dihydromorphine, which mediates the majority of its analgesic effects. Owing to the low oral bioavailibility of dihydrocodeine (20%), and its subsequent metabolism to active compounds, it is likely that doses below 30mg are sub therapeutic for analgesia.
References
[edit]- British National Formulary 2004
- Merck Index 13th Edition
- Oxford textbook of clinical pharmacology Second Edition (09. October 1992)
- Martindale: The complete drug reference 35th Edition (2007)
- Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th Edition
- Information on the packaging leaflet in Co-dydramol from Hammed